Home › Funds › TPG GP A, LLC › AMRX
TPG GP A, LLC position in AMRX
AMNEAL PHARMACEUTICALS INC · Health Care
TPG GP A, LLC reported holding 12,328,767 shares of AMRX (AMNEAL PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$213.4M, representing 4.39% of its reported portfolio and ranking #7 among its reported holdings. TPG GP A, LLC has disclosed AMRX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How TPG GP A, LLC's AMRX position evolved
TPG GP A, LLC first disclosed a stake in AMRX in Q3 2023 at 12,328,767 shares (US$52.0M). The position peaked in Q2 2026 at 12,328,767 shares, worth US$213.4M. Across 12 filings, TPG GP A, LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 12,328,767 shares valued at US$213.4M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 12.33M | $52.03M | New |
| Q4 2023 | 12.33M | $74.84M | Hold |
| Q1 2024 | 12.33M | $74.71M | Hold |
| Q2 2024 | 12.33M | $78.29M | Hold |
| Q3 2024 | 12.33M | $102.58M | Hold |
| Q4 2024 | 12.33M | $97.64M | Hold |
| Q1 2025 | 12.33M | $103.32M | Hold |
| Q2 2025 | 12.33M | $99.74M | Hold |
| Q3 2025 | 12.33M | $123.41M | Hold |
| Q4 2025 | 12.33M | $155.34M | Hold |
| Q1 2026 | 12.33M | $153.25M | Hold |
| Q2 2026 | 12.33M | $213.41M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About AMRX and 13F data
AMRX (AMNEAL PHARMACEUTICALS INC) is a Health Care company. 47 other funds we track also report a position in AMRX — the largest reported positions include Rubric Capital Management LP (US$176.0M), Nantahala Capital Management, LLC (US$39.3M), Westshore Wealth, LLC (US$23.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding AMRX
- Rubric Capital Management LP 10.17M sh · $176.02M · Q2 2026
- Nantahala Capital Management, LLC 2.27M sh · $39.27M · Q2 2026
- Westshore Wealth, LLC 1.37M sh · $23.65M · Q2 2026
- BlackBarn Capital Partners LP 1.30M sh · $22.50M · Q2 2026
- Penn Capital Management Company, LLC 1.18M sh · $20.48M · Q2 2026
- TUCKER ASSET MANAGEMENT LLC 1.01M sh · $17.50M · Q2 2026
- Phocas Financial Corp. 819.48K sh · $14.19M · Q2 2026
More on TPG GP A, LLC
FAQ
How long has TPG GP A, LLC held AMRX?
TPG GP A, LLC has disclosed AMRX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is TPG GP A, LLC's current position in AMRX?
As of Q2 2026, TPG GP A, LLC holds 12.33M shares of AMRX (AMNEAL PHARMACEUTICALS INC), valued at $213.41M, representing 4.39% of its reported portfolio and ranking #7.
Has TPG GP A, LLC been buying or selling AMRX?
In the latest 13F filing (Q2 2026), TPG GP A, LLC held unchanged its position in AMRX. The position peaked in Q2 2026 at 12.33M shares.
Which other funds hold AMRX?
Other major institutional holders of AMRX include Rubric Capital Management LP, Nantahala Capital Management, LLC, Westshore Wealth, LLC, among 47 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.